• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子风暴在冠状病毒感染中的启示作用。

An enlightening role for cytokine storm in coronavirus infection.

机构信息

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

出版信息

Clin Immunol. 2021 Jan;222:108615. doi: 10.1016/j.clim.2020.108615. Epub 2020 Oct 23.

DOI:10.1016/j.clim.2020.108615
PMID:33203513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7583583/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in Wuhan, China has dispersed rapidly worldwide. Although most patients present with mild fever, cough with varying pulmonary shadows, a significant portion still develops severe respiratory dysfunction. And these severe cases are often associated with manifestations outside the respiratory tract. Currently, it is not difficult to find inflammatory cytokines upregulated in the blood of infected patients. However, some complications in addition to respiratory system with the coronavirus disease 2019 (COVID-19) are impossible to explain or cannot be attributed to virus itself. Thus excessive cytokines and their potentially fatal adverse effects are probably the answer to the multiple organ dysfunctions and growing mortality. This review provides a comprehensive overview of the mechanisms underlying cytokine storm, summarizes its pathophysiology and improves understanding of cytokine storm associated with coronavirus infections by comparing SARS-CoV-2 with severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV).

摘要

新型冠状病毒病 2019(COVID-19)是由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的,该病毒最初于 2019 年 12 月在中国武汉被发现。这种新型冠状病毒迅速在全球范围内传播,给全球公共卫生带来了前所未有的挑战。尽管大多数患者表现为轻度发热、咳嗽伴不同程度的肺部阴影,但仍有相当一部分患者出现严重的呼吸功能障碍。这些严重病例常伴有呼吸道以外的表现。目前,在感染患者的血液中发现炎症细胞因子上调并不困难。然而,除了 COVID-19 之外,还有一些并发症是不可能解释的,或者不能归因于病毒本身。因此,细胞因子的过度释放及其潜在的致命不良反应可能是多器官功能障碍和死亡率上升的原因。本文全面综述了细胞因子风暴的发生机制,通过比较 SARS-CoV-2 与严重急性呼吸综合征冠状病毒(SARS-CoV)和中东呼吸综合征冠状病毒(MERS-CoV),总结了其病理生理学,并加深了对冠状病毒感染相关细胞因子风暴的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e5c/7583583/f5600d0fff70/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e5c/7583583/91c0b77cf96e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e5c/7583583/f5600d0fff70/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e5c/7583583/91c0b77cf96e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e5c/7583583/f5600d0fff70/gr2_lrg.jpg

相似文献

1
An enlightening role for cytokine storm in coronavirus infection.细胞因子风暴在冠状病毒感染中的启示作用。
Clin Immunol. 2021 Jan;222:108615. doi: 10.1016/j.clim.2020.108615. Epub 2020 Oct 23.
2
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.SARS-CoV、MERS-CoV 和 SARS-CoV-2 感染中的免疫致病反应和血液病理效应的重点。
Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020.
3
SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.SARS-CoV-2 引起的细胞因子反应与其他严重感染患者中导致细胞因子风暴的呼吸道病毒不同。
Front Immunol. 2021 Mar 1;12:629193. doi: 10.3389/fimmu.2021.629193. eCollection 2021.
4
Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.概述:严重急性呼吸系统综合征的历史和儿科视角:新型还是类似 SARS。
Pediatr Pulmonol. 2020 Jul;55(7):1584-1591. doi: 10.1002/ppul.24810. Epub 2020 Jun 1.
5
Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?为何 COVID-19 的传播效率和攻击性比以往冠状病毒疫情中的病毒传播更高?
Biomolecules. 2020 Sep 11;10(9):1312. doi: 10.3390/biom10091312.
6
Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.冠状病毒(SARS-CoV、MERS-CoV和SARS-CoV-2)所致肺炎患者的免疫环境调节
Aging (Albany NY). 2020 May 2;12(9):7639-7651. doi: 10.18632/aging.103101.
7
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病(COVID-19)疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
8
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.COVID-19 中的细胞因子风暴:从病毒感染到免疫反应、诊断和治疗。
Int J Biol Sci. 2022 Jan 1;18(2):459-472. doi: 10.7150/ijbs.59272. eCollection 2022.
9
Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned.流感感染、严重急性呼吸综合征、中东呼吸综合征和 COVID-19:细胞因子风暴——共同的特征和吸取的教训。
Clin Immunol. 2021 Feb;223:108652. doi: 10.1016/j.clim.2020.108652. Epub 2020 Dec 14.
10
Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.先天免疫对高致病性冠状病毒和其他重要呼吸道病毒感染的反应。
Front Immunol. 2020 Aug 18;11:1979. doi: 10.3389/fimmu.2020.01979. eCollection 2020.

引用本文的文献

1
The critical impacts of cytokine storms in respiratory disorders.细胞因子风暴在呼吸系统疾病中的关键影响。
Heliyon. 2024 Apr 17;10(9):e29769. doi: 10.1016/j.heliyon.2024.e29769. eCollection 2024 May 15.
2
Involvement of NLRP3 Inflammasome in SARS-Cov-2-Induced Multiorgan Dysfunction in Patients with COVID-19: A Review of Molecular Mechanisms.NLRP3炎性小体在新型冠状病毒肺炎患者严重急性呼吸综合征冠状病毒2诱导的多器官功能障碍中的作用:分子机制综述
Tanaffos. 2023 Jan;22(1):40-52.
3
Safety and Outcomes With Combination Therapy With Sarilumab and Baricitinib for Severe COVID-19 Respiratory Infection in Cancer Patients.

本文引用的文献

1
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis.作者更正:一种动态的COVID-19免疫特征包括与不良预后的关联。
Nat Med. 2020 Oct;26(10):1663. doi: 10.1038/s41591-020-1079-x.
2
Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome.直面争议:白细胞介素-6 与 COVID-19 细胞因子风暴综合征。
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.03006-2020. Print 2020 Oct.
3
Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients.在住院的COVID-19患者中使用白细胞介素-6受体拮抗剂托珠单抗。
沙利鲁单抗联合巴瑞替尼治疗癌症患者严重 COVID-19 呼吸道感染的安全性和结局。
Cancer Control. 2023 Jan-Dec;30:10732748231205864. doi: 10.1177/10732748231205864.
4
Wastewater pandemic preparedness: Toward an end-to-end pathogen monitoring program.污水疫情防范:建立端到端的病原体监测计划。
Front Public Health. 2023 Mar 21;11:1137881. doi: 10.3389/fpubh.2023.1137881. eCollection 2023.
5
Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence.牙周炎、新冠病毒病与心血管代谢并发症之间的关联:分子机制与临床证据
Metabolites. 2022 Dec 26;13(1):40. doi: 10.3390/metabo13010040.
6
Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2.明确表征 SARS-CoV-2 发病机制的分子机制。
J Microbiol Biotechnol. 2022 Sep 28;32(9):1073-1085. doi: 10.4014/jmb.2206.06064. Epub 2022 Aug 23.
7
Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patients.基于mRNA-微RNA整合及血浆蛋白分析的干扰素信号在危重症COVID-19患者中的意义
Mol Ther Nucleic Acids. 2022 Sep 13;29:343-353. doi: 10.1016/j.omtn.2022.07.005. Epub 2022 Jul 13.
8
Social Determinants of Health Factors for Gene-Environment COVID-19 Research: Challenges and Opportunities.基因-环境新冠病毒研究中的健康因素的社会决定因素:挑战与机遇
Adv Genet (Hoboken). 2022 Jun;3(2):2100056. doi: 10.1002/ggn2.202100056. Epub 2022 Mar 9.
9
The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy.严重急性呼吸综合征冠状病毒 2 感染对固有免疫的调节作用及抗击 COVID-19 炎症反应的治疗策略。
J Biomed Sci. 2022 May 3;29(1):27. doi: 10.1186/s12929-022-00811-4.
10
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity.SARS-CoV-2 逃避宿主抗病毒先天免疫的分子机制。
Virol J. 2022 Mar 19;19(1):49. doi: 10.1186/s12985-022-01783-5.
J Intern Med. 2021 Mar;289(3):430-433. doi: 10.1111/joim.13163. Epub 2020 Oct 20.
4
IL-6-based mortality risk model for hospitalized patients with COVID-19.基于 IL-6 的 COVID-19 住院患者死亡风险模型。
J Allergy Clin Immunol. 2020 Oct;146(4):799-807.e9. doi: 10.1016/j.jaci.2020.07.009. Epub 2020 Jul 22.
5
Is a "Cytokine Storm" Relevant to COVID-19?“细胞因子风暴”与新冠病毒病有关吗?
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.
6
Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment.罗沙司他抑制细胞因子信号转导及其在 COVID-19 治疗中的意义。
Clin Immunol. 2020 Sep;218:108517. doi: 10.1016/j.clim.2020.108517. Epub 2020 Jun 23.
7
Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndrome.新型冠状病毒肺炎相关细胞因子风暴综合征的改善:与嵌合抗原受体T细胞细胞因子释放综合征的相似之处
Br J Haematol. 2020 Aug;190(3):e150-e154. doi: 10.1111/bjh.16961. Epub 2020 Jul 16.
8
COVID-19 pneumonia: CD8 T and NK cells are decreased in number but compensatory increased in cytotoxic potential.COVID-19 肺炎:CD8 T 细胞和 NK 细胞数量减少,但细胞毒性潜能代偿性增加。
Clin Immunol. 2020 Sep;218:108516. doi: 10.1016/j.clim.2020.108516. Epub 2020 Jun 20.
9
IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?白细胞介素-6抑制剂治疗重症新型冠状病毒肺炎:一种有前景的疗法?
Pharmaceut Med. 2020 Aug;34(4):223-231. doi: 10.1007/s40290-020-00342-z.
10
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.